摘要
需要器官移植的患者经常经受不同的皮肤病,需要进行免疫抑制治疗。具体的皮肤副作用比如痤疮、多毛症或其他毛囊皮脂腺紊乱、牙龈增生、紫癜或毛细管扩张通常与免疫抑制介导有关。大部分情况是温和的,但是可能会影响患者的审美是生命的质量并且减少了治疗的依附性。此外,器官移植受体经常会受到皮肤感染,间接导致免疫抑制。疱疹病毒的再激活通常是移植后几个月,然而党减少免疫抑制之后,皮肤感染主要由人乳头状瘤宾度感染并且表现出局限性。很少有细菌感染。长期的免疫抑制治疗主要体现在肿瘤早期和皮肤癌的发展,这有一定的风险使得时间延长和对病人的存活有明显的影响。本文对近几年的文献报道的数据对该主题进行综述,为了了解器官移植受体患者与使用免疫抑制药物相关的主要皮肤紊乱的特征,包括其风险、流行病学、临床表现与管理方面的知识。
关键词: 皮肤,副作用,免疫抑制治疗,器官移植
Current Drug Targets
Title:Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ Recipients
Volume: 18 Issue: 4
关键词: 皮肤,副作用,免疫抑制治疗,器官移植
摘要: Patients who underwent solid organ transplantation frequently suffer from different skin diseases, as consequence of the immunosuppressive treatment. Specific cutaneous side effects such as acne, hypertricosis or other pilosebaceous unit disorders, gingival hyperplasia, purpura or teleangiectasies are commonly associated to immunosuppressive medications. The majority of these conditions are benign, but the aesthetic concern may affect the patient is quality of life and reduce the adherence to the therapy. Moreover, solid organ transplant recipients frequently develop skin infections, as an indirect consequence of the immunosuppressive regimens. Herpes virus reactivation is more common few months after transplantation, whereas when the immunosuppression is reduced, the skin infections are mainly represented by human papilloma virus infections and localized mycosis. Bacterial infections are relatively rare. Long-term consequences of the immunosuppressive therapy are represented by development of precancerosis and skin cancers, with a risk that enhances over the time and a significant impact on patient survival. The aim of this paper is to provide an overview of the data published in the recent literature about this topic, in order to characterize the main skin disorders associated to the use of immunosuppressive drugs in solid organ recipients, giving information about their risk, epidemiology, clinical manifestations and management.
Export Options
About this article
Cite this article as:
Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ Recipients, Current Drug Targets 2017; 18 (4) . https://dx.doi.org/10.2174/1389450117666160112115524
DOI https://dx.doi.org/10.2174/1389450117666160112115524 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multidisciplinary Management of Aneurysmal Bone Cyst in Paediatric Patients:
A Case Report
Current Medical Imaging Skp2 Inhibitors: Novel Anticancer Strategies
Current Medicinal Chemistry Creating A Standard of Care for Fertility Preservation
Current Women`s Health Reviews Modulation of Matrix Metalloproteinases by Plant-derived Products
Current Cancer Drug Targets Recent Advance in Polymer Based Microspheric Systems for Controlled Protein and Peptide Delivery
Current Medicinal Chemistry MATra - Magnet Assisted Transfection: Combining Nanotechnology and Magnetic Forces to Improve Intracellular Delivery of Nucleic Acids
Current Pharmaceutical Biotechnology Occurrence and Biological Activities of Phenylpropionyl Iridoids
Mini-Reviews in Medicinal Chemistry Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Dendrimers in Therapy for Breast and Colorectal Cancer
Current Medicinal Chemistry Src Kinase Inhibitors: An Update on Patented Compounds
Current Medicinal Chemistry Chemotherapy and Cardiotoxicity in Hematologic Malignancies
Current Cancer Drug Targets Curcumin has Bright Prospects for the Treatment of Inflammatory Bowel Disease
Current Pharmaceutical Design Immunomodulatory Activities of Glucocorticoids: Insights from Transgenesis and Gene Targeting
Current Pharmaceutical Design Regenerative Medicine and Nanotechnology Approaches against Cardiovascular Diseases: Recent Advances and Future Prospective
Current Stem Cell Research & Therapy Nanomaterials for Photohyperthermia: A Review
Current Pharmaceutical Design Cell Physiological Behavior in the Context of Local Hypothermia
New Emirates Medical Journal The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases
Current Protein & Peptide Science Modulation of Shape and Size-Dependent Characteristics of Nanoparticles
Current Nanomedicine Chemotherapy of Chagas Disease
Current Pharmaceutical Design Mesenchymal Stem Cells for Anti-Cancer Drug Delivery
Recent Patents on Anti-Cancer Drug Discovery